chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hives all over my body; Swollen eyes; Swollen knees elbows; Chills; This is a spontaneous report from a contactable Other Health Professional. A 41-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL9266, expiry date was not reported), dose 2 via an unspecified route of administration, administered in Arm Right on 22Feb2021 14:30, 2ND DOSE, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient had no allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior vaccination and since the vaccination. Historical vaccine includes BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL9264, expiry date was not reported), dose 1 via an unspecified route of administration, administered in Arm Right on 31Jan2021 13.00, Single for COVID-19 immunization. The patient experienced Hives all over my body, swollen eyes, swollen knees elbows, chills on 22Feb2021 14:30. Patient was treated with Dosepk 4 MG. Adverse events resulted in Emergency room/department or urgent care. The clinical outcome of the events were not recovered.
I started with a sore throat and a fever. I tested myself on the 2nd of June and was positive. I was given PAXLOVID. It was the PAXLOVID gave me a Hepatitis flare up so I had to stop. I tried to get the infusion but they could not do it because I had started the PAXLOVID. The symptoms were the same for my asthma and COVID-19 symptoms. I had shortness of breath, coughing and body aches. It was almost like having the flu. I took ibuprofen, purchased an air purifiers and used a lot of nebulizer medication for breathing treatments. It took me about 5 weeks to completely recover. I went back to my doctor for a check up and ended up having a bacterial infections but the doctor did not think it related.
Two weeks after receiving my second dose I began to break out into a rash. It started on my hands and over the next 2 days moved up my arms, neck, and face. By Monday morning 8/9 my face was incredibly swollen to the point I could barely see out of my eyes. My throat and tongue had NO swelling and I never felt my breathing was compromised.  Starting Saturday 8/7 I began taking 50mg of benadryl  several times per day. The rash on my arms/hands resulted in multiple vesicles  that scabbed over and left me feeling like I looked like a meth user. It is now the 20th and my skin is still shedding from the rash. I also still have a lot of scabs from the larger vesicles.
On 06/28/2021, a rash on my back between my shoulder blades, upper back and it hurt. A couple of days later, my doctor, he  diagnosed me with shingles.  Treatments : oral-Valtrex  and topical. He quarantined me for 10 days and went back to the doctor's on 07/16/2021 and got the all clear.
Generalized body aches, elevated temp of 102 to 102.5 began @ 2am after receiving tdap; 1 gm Tylenol initially brought temp down to 101.0; pt then called later same day @ 3:30pm to inform MD office that temp was up to 106.0. Bk
PT DESCRIBES INFLAMED INJECTION SITE; RED, WARM TO THE TOUCH, "KNOT"; CONTINUING TO MONITOR SYMPTOMS FOR IMPROVEMENT/WORSENING
17 year old Vaccinated with Moderna COVID-19 Vaccine on 08JUL2021; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old Vaccinated with Moderna COVID-19 Vaccine on 08JUL2021) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old Vaccinated with Moderna COVID-19 Vaccine on 08JUL2021). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old Vaccinated with Moderna COVID-19 Vaccine on 08JUL2021) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow-up received contains No new Information
Client experienced numbness and tingling of her hands, feet, arms and legs and the numbness and tingling has been getting worse each day and involves more of her leg each day.  She called the clinic and was told it could be GBS and then called the Community Health office and was referred to her Medical Provider on 11/10/2009 at 01:10 PM.
Symptoms started on the 30th with sore throat, headache, tiredness and aches and pains. My husband already tested positive that's why I was suspicious it was Covid. The first test I did was negative but then I tested again on June 1st and it was positive. On May 29th in the morning our neighbor told use he had tested positive and we had been with him days before. The doctor gave me PAXLOVID 5 day treatment.
Patient came in to get his second covid vaccine.  He was given the shot and it had only been 8 days since his first shot.
Swollen red hot mass in mothe forearms. Headache behind eyes. Nausea. Given Benadryl at Dr office around 10:15 am. Mass was outlined with pen to watch for growth of the redness.
Patient had continuous coughing start within 10 minutes of dose 2. O2 sat remained normal with clear lung sounds throughout 40 minute observation. Patient coughing did not respond to albuterol inhaler. Patient and her father who was present opted to be transferred to ER via ambulance for further observation.
tested positive for SARS-CoV-2 by reverse transcriptase polymerase; COVID-19; This is a literature report for the following literature source(s):  A 68-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3, (booster dose) single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "decompensated hepatitis C cirrhosis" (unspecified if ongoing); "hepatitis C" (unspecified if ongoing); "hepatocellular carcinoma" (unspecified if ongoing), notes: native MELD score 7; "hepatopulmonary syndrome" (unspecified if ongoing); "refractory hepatic hydrothorax" (unspecified if ongoing); "sarcopenia" (unspecified if ongoing); "frailty" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (hospitalization, medically significant), outcome "unknown", described as "tested positive for SARS-CoV-2 by reverse transcriptase polymerase"; COVID-19 (hospitalization, medically significant), outcome "unknown". The patient underwent the following laboratory tests and procedures: Chest X-ray: demonstrated chronic bilateral pleural effusions, notes: no other abnormalities; Model for End-Stage Liver Disease (MELD) score: 7; SARS-CoV-2 test: positive, notes: preoperative evaluation; Negative, notes: 1 week prior. Therapeutic measures were taken as a result of covid-19.; Sender's Comments: The efficacy of a vaccine varies individually and can be affected by different factors including product potency; however, a contributory role of BNT162B2 to the events COVID-19 and drug ineffective cannot be ruled out. Potential contributors include patient's advanced age and underlying decompensated hepatitis C, hepatic cirrhosis, hepatocellular carcinoma, hepatopulmonary syndrome and other co-morbidities.,Linked Report(s) : US-PFIZER INC-202201346497 Same Article/drug/event and different patient.;US-PFIZER INC-PV202200116532 Same Article and different patient/drug/event;
exactly 7 days out pt developed L upper arm redness swelling firmness itching, self resolved in 1wk
pt recvd vax & exp mild case of chickenpox 5 days p/vax;pt was exposed to natural varicella 10 days prior to vax;No further details were provided;
Although you can only list one date on this form, Patient experienced a big spike in his blood sugar after each dose, including the first dose on 3/30/21  lot 026b21a and the booster 11/4/21, lot 091d21a.  Although he doesn't remember his blood sugar values exactly after doses 1 and 2, he remembers that they were really high. After the booster, his blood sugar spiked to 500.  The nurse said that another diabetic patient reported the same thing after his shots.
slight hearing loss; I started with ringing in my ears; unable to sleep; This is a spontaneous report from a contactable consumer (patient). An 82-year-old-female consumer (no pregnant) received the second dose of BNT162B2 via an unspecified route of administration on the left arm  on 26Mar2021 at 02:00 PM (Lot Number: ER8732) at the age of 82-year-old as single dose for COVID-19 immunization. Medical history included history of high blood pressure. The patient previously received the first dose of BNT162B2 via an unspecified route of administration on the left arm on 05Mar2021 at 02:00 PM (Lot Number: EN6204) at the age of 82-year-old as single dose for COVID-19 immunization and no reaction on previous exposure to drug. The patient previously took Percocet (PERCOCET [OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE; PARACETAMOL]) used for unknown indication and experienced drug allergy and took codeine used for an unknown indication and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received BP Medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 at 08:00 AM, the patient started with ringing in ears (head) that had never stopped since that day. The patient unable to sleep since that day due to the constant noise. The patient had been to primary care Dr. and also an ENT Dr. The patient not deaf but do had slight hearing loss. The events all result in doctor or other healthcare professional office/clinic visit and the events of hearing loss and ringing in ears also result in disability permanent damage. The treatment was received with Steroids x 10 days. The outcome of event was not recovered.
On day 2 after vaccine got chickenpox like rash on head,neck,arms after second vaccine got fever of 102 the rash got worse, chills headache and all over aches. Now the rash or hives don't go away.what do I do to stop this?
No adverse event; not receive the dose of the bivalent booster as it was not properly injected in the arm and instead sprayed in the air and in the arm; Dose was sprayed in the air and in the arm; This spontaneous case was reported by a patient and describes the occurrence of WRONG TECHNIQUE IN DEVICE USAGE PROCESS (not receive the dose of the bivalent booster as it was not properly injected in the arm and instead sprayed in the air and in the arm), ACCIDENTAL UNDERDOSE (Dose was sprayed in the air and in the arm) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 017hzza) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-Oct-2022, the patient experienced WRONG TECHNIQUE IN DEVICE USAGE PROCESS (not receive the dose of the bivalent booster as it was not properly injected in the arm and instead sprayed in the air and in the arm) and ACCIDENTAL UNDERDOSE (Dose was sprayed in the air and in the arm). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG TECHNIQUE IN DEVICE USAGE PROCESS (not receive the dose of the bivalent booster as it was not properly injected in the arm and instead sprayed in the air and in the arm), ACCIDENTAL UNDERDOSE (Dose was sprayed in the air and in the arm) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant medication was reported.   Caller received 4 doses of the Moderna COVID19 vaccine in the past   Caller did not receive the dose of the bivalent booster as it was not properly injected in the arm and instead sprayed in the air and in the arm  No treatment information was reported
Itching, redness.  Given Epinephrine 0.3 mg subq
A 33 year old male patient experienced muscle spasms after being treated for exposure to a bat with RabAvert, lot number 334011, expiration 12/06.  Medical history and concomitant medication remained unspecified.  RabAvert (1ml, intramuscularly) was received on 08/02/2004 (left deltoid), 08/05/2004 (right deltoid) and 08/09/2004 (left deltoid). On 08/10/2004 the patient experienced muscle spasms in his left arm which he described as "constant, would disappear for an hour or so, then would return".  His physician felt it was a "local reaction", and advised him to call again on 08/14/2004 if it was continuing.  The muscle spasms stopped on 08/12/2004 with no treatment.
patient received her 2nd dose too early/received it 21 days after the 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received her 2nd dose too early/received it 21 days after the 1st dose) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received her 2nd dose too early/received it 21 days after the 1st dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received her 2nd dose too early/received it 21 days after the 1st dose) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.   Patient received second dose of the Moderna COVID-19 vaccine at 21 days interval, after the first dose. Patient was told by another pharmacist that the second dose was considered invalid due to this and should repeat the dose.  The reporter did not have any further information on the patient as patient did not receive the prior doses of the Moderna vaccine at his facility.   No treatment information was provided by the reporter.
Developed dysphagia shortly after arriving in another country and after a gastrointestinal illness accompanied by dizziness. Worsened dysphagia, and now in 2011 chokes on some foods and liquids. Had ED visit.
Woke up this morning with hives, will take benadryl and apply calamine as needed
8/7/2021: Patient is a pleasant 82-year-old male c significant past medical history of CVA c left-sided deficits, P 80, hypertension, hyperlipidemia, diabetes, heart failure, carotid artery disease history of endarterectomy.  Patient presents to Hospital from nursing home for slight cough.  He did test positive for COVID on 8/7/2021 but is been satting well on room air.  Chest x-ray is still in progress.  Laboratory significant for a dramatic increase in creatinine.  Creatinine of 3.42 on 08/07 which has increased from 1.84 2 days prior.  8/12/2021: patient to hospice 8/19/2021: patient expired
Day after vaccine - chills, fever, achy joints -  that lasted just a day or not quite. About a month  later- it kicked up my fibromyalgia. Nerve pain in my right arm; fatigue. My right knee and ankles get pain - so those were painful - but the arm pain was worse and it was aggravated by using it. My strength is much less in my arm right now. I had it about 10 years ago - I had it for about 8 years and then it went away  in 2009 or 2010 and I haven't had it sense until now.  If I need to I take Ibuprofen 800, I take it. I upped the dose of Metoprolol. It also made me other chronic conditions a little worse. I still get days when the symptoms are worse than they use to be. I spoke to a doctor at work. The fatigue is getting better. And I can walk and get up out of chair etc - last time it happened to me for those 8 years, it was much worse. It is about 1/4 of what I experienced last time.
Patient presented to facility with SOB. Patient was diagnosed twit COVID pneumonia on 8/17/21. Patient has been to ED multiple times with same complaints. Pt admitted after O2 sats were in the low 70s.
pt recv vax & devel rash & fever & was felt to have a hypersensitivity rxn to MMR;
4 hrs p/vax pt displayed fussiness, whimpering, & did not want to be held or touched for 4 hrs; pt did not have a fever;
8 hours after receiving injection, started having a sore throat.  48 hours after injection noticed a small grape size lump/knot close to collar bone (lymph node?) on left side which is the injection side.  72 hours after injection, I had lost my voice, not totally.  Sounds like I'm whispering when I talk.  I also had the normal reported sore arm, but was quite bothersome for 3+ days.  I have also noticed some shortness of breath and still quite tired after doing several small chores.  I am currently on day 11 after injection, and have another smaller lump/knot beside the first one that appeared by my left collar bone. The only side effect that has dissipated is the sore arm, I still am having fatigue, shortness of breath, lumps near collarbone and loss of voice.   I have not seeked medical treatment since I have no health insurance.  I felt like these would subside, but have not so far.  I am really hesitant to receive my 2nd dose since claims are that it is worse that the first, regarding side effects.  I feel that my body has not recuperated from trying to build up my immunity.   As stated above, my side effects have not subsided as of today's date, 11 days after receiving the 1st dose injection.
right side of face, lips droopped a little; throat irritation; lymph nodes swelling - under her chin; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PARALYSIS (right side of face, lips droopped a little) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Total hysterectomy in 2016 and Colonoscopy on 14-May-2021. Concurrent medical conditions included HIV disease, Spinal cord injury and Nerve injury.    On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, the patient experienced FACIAL PARALYSIS (right side of face, lips droopped a little) (seriousness criterion medically significant), THROAT IRRITATION (throat irritation) and LYMPHADENOPATHY (lymph nodes swelling - under her chin). The patient was treated with NAPROXEN for Inflammation, at an unspecified dose and frequency. On 15-Jun-2021, FACIAL PARALYSIS (right side of face, lips droopped a little) had resolved. At the time of the report, THROAT IRRITATION (throat irritation) had not resolved and LYMPHADENOPATHY (lymph nodes swelling - under her chin) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication reporter were hypertension medication, hyperlipidemia medication and HIV medication. Cough lozenges were the treatment medication reported by reporter. Patient also said that she did not have these symptoms before the COVID shot  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Within a couple of minutes of the first dose I started to have shortness of breath, wheezing and tightness in my chest. The day after I started to get PVC Tachycardia and Bradycardia. It was similar to the symptoms I had with Covid-19. I also haad severe fatigue bone pain,  muscle pain nausea headaches. Fevers, night sweats but no cough. I had Covid-19 in March 2020 and I required a lot of medical treatment. I was on bed rest for 90 days and required Physical Therapy and Occupational Therapy. I have also had Dura Swelling reoccur since the vaccine. Before the vaccine my heart problems were controlled and most symptoms had resolved by December of 2020.  All of these Covid-19 like symptoms persisted for two weeks after the vaccine. I was given a course of Prednisone and that helped most symptoms. My heart medications have needed to be greatly increased since the vaccine. My Heart Function has also decreased. I did not have any symptoms after the second dose of the vaccine and it seemed to actually improve all my symptoms except for my heart and brain injuries.
Second dose of Pfizer on 9-15-21: She reports having a HA, arm soreness and fatigue for the first 48 hours after vaccination. This resolved and on day 3 she noticed 3-4 very large L supraclavicular lymph nodes. 5 days later (10 days after immunization) the left side of her neck/trapezius region became stiff, "felt swollen" and she began noticing weakness and decreased ROM to L shoulder. Over the next 2 days she developed 8/10 shoulder pain (unable to sleep), worsening weakness/decreased ROM.   Symptoms: PAIN IN UNSPECIFIED JOINT(M2550), WEAKNESS(R531), LOCALIZED ENLARGED LYMPH NODES(R590).
11 days after a ringing and vibrating in her ear; This is a spontaneous report from a contactable consumer (patient herself). A 63-years-old female patient received second dose of bnt162b2 (Solution injection; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 63-years-old) as single dose for COVID-19 immunisation. Patient previously received first dose of bnt162b2 (Solution injection; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, patient experienced 11 days after a ringing and vibrating in her ear. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
This spontaneous report was received from a certified medical assistant concerning a 73 year old female patient with fibromyalgia and osteoarthritis. Height of the patient was 65 inches and weight of the patient was 208. On 05-APR-2013, at 09:00 am, the patient was vaccinated with dose 1 PNEUMOVAX23 (lot number reported as H022062, expiry date unspecified), intramuscularly in the right deltoid. There was no illness at the time of vaccination. No concomitant medications were reported. On 05-APR-2013, at 09:00 am, the patient experienced gradual increasing pain in the right shoulder. There was not erythema or induration. The patient visited a doctor. The patient was treated with ADVIL. On an unknown date, X-ray of right shoulder was performed which revealed arthritis of acromioclavicular (AC) joint and the patient was treated with calcium (ca) supplements tablets. On an unknown date, ultrasound scan (USS) was performed and the result was unknown. The patient was recovering from the pain as the pain decreased with ADVIL. The relatedness for the event was unknown for PNEUMOVAX23. Additional information has been requested.